EVAg

This SARS-CoV-2 strain was isolated from a COVID-19 patient from Slovakia in March 2020. Its complete sequence is deposited on GISAID.org under the accession ID EPI_ISL_417879. The virus is freeze-dried.

This SARS-CoV-2 strain was isolated from a COVID-19 patient from Slovakia in march 2020. Its complete sequence is deposited on GISAID.org under the accesion ID EPI_ISL_417879.

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp (IP2/IP4) gene, for 100 Rxns (Target designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the RdRp (IP4) gene. Primers and Probe sequences designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized encapsidated RNA for SARS-CoV-2 real time RT-PCR targeting region of the RdRp (IP2/IP4) gene (for 100 Rxns) AND Lyophilized ready-to-use primers and probe (Lyoph-P&P) for real time RT-PCR (96 rxns in the form of 4x24 rnxs). Target, primers and probe designed by Institut Pasteur Paris. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase

Infectious cell culture supernatant containing Human 2019-nCoV strain 2019-nCoV/Italy-INMI1. This strain is preserved under Viral Storage Medium -80C. To confirm its identity the virus has been completely sequenced.

Infectious cellculture supernatant of human 2019-nCoV

Infectious cell culture supernatant containing SARS-Cov-2 (strain Slovenia/SI-4265/20). This strain is preserved under Viral Storage Medium -80C. To confirm its identity the virus has been completely sequenced.

A bundle of rodent-borne virus stocks to be used for EQA preparation

Expression plasmids for the production of flaviviruses NS5 full length (MTase and RdRp domains). Synthetic gene optimized for E. coli. Coding sequence fused at its 5' with a cleavage 6His tag coding sequence

Infectious cell culture supernatant of human 2019-nCoV

Infectious cell culture supernatant of human 2019-nCoV

Hybridoma cell culture supernatant containing anti-BoHV 1 antibodies; targeted antigen: envelope; clone: 4H9; immunization antigen: recombinant envelope protein of BoHV 1 strain "Schönböken"

Bundle of different arenavirus RNA for various studies

The in vitro transcribed RNA is the control for the first-line screening assay termed E gene assay. The SARS-CoV full virus RNA is required to control the two confirmatory assays. Dislaimer: Import permit maybe be needed in your country for the SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry.

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the E gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

Zika virus, strain 800/16. This Zika virus is freeze dried. Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been fully sequenced.

Expression plasmid for the Nterminal Domain of the MERS CoV Nucleocapsid coding sequence in fusion with a TRX/6-His tag encoding sequence at its 5'. For expression in E. coli

Freeze dried Human Adenovirus C serotype 1 strain UVE/ADV-C/2012/FR/2391, France, 2012, partial sequence.

Recombinant expressed and purified receptor-binding domain (RBD) of SARS-CoV-2 for serological assays. The Protein was expressed in Expi293 cells and purified via Strep-Tactin XT and provided in Elution Buffer ( 100mM Tris-HCl; pH 8.0, 150mM NaCl, 1mM EDTA, 50mM Biotin).

Recombinant expressed and purified receptor-binding domain (RBD) of SARS-CoV-2 for serological assays. The Protein was expressed in Expi293 cells and purified via a HisTag and provided in Elution Buffer (50 mM NaH2PO4, 300 mM NaCl, 0,05% Tween, 250 mM Imidazole, pH 8.0).

C-terminal domain of the SARS-CoV-2 nucleprotein (247-418). Pure recombinant protein produced in E. coli and fused with a Avi tag and a Hexa-Hisitidine tag.

N-terminal domain of the SARS-CoV-2 nucleprotein (1-180). Pure recombinant protein produced in E. coli and fused with a Avi tag and a Hexa-Hisitidine tag.

Middle East respiratory syndrome (MERS) Coronavirus, strain IP/COV/MERS/Hu/France/FRA2

Porcine reproductive and respiratory syndrome virus 1 (PRRSV-1), strain "Cobbelsdorf DZ 2/91", Germany 1991, infectious cell culture supernatant